PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Hospital Medicine, Mount Carmel East Hospital, 6001 E Broad Street, Columbus, OH, 43213, USA. namrat09@gmail.com.\', \'Department of Internal Medicine, University of Illinois at Peoria, Peoria, IL, 61637, USA.\', \'Department of Internal Medicine, Greenfield Health, Portland, OR, USA.\', \'Department of Internal Medicine, University of Florida, Gainesville, FL, USA.\', \'Department of Cardiovascular Medicine, Baylor Heart and Vascular Institute, Dallas, TX, USA.\', \'Department of Internal Medicine, Texas A&M College of Medicine Health Science Center, Dallas, TX, USA.\', \'Department of Internal Medicine, Baylor University Medical Center, Dallas, TX, USA.\', \'Department of Cardiovascular Medicine, Baylor Heart and Vascular Hospital, Dallas, TX, USA.\', \'Department of Hospital Medicine, CHI St Vincent Infirmary, Little Rock, AR, USA.\', \'Department of Nephrology and Hypertension, University of Utah, Salt Lake City, UT, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s40256-020-00431-z
?:doi
?:hasPublicationType
?:journal
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
is ?:pmid of
?:pmid
?:pmid
  • 32748336
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Current Overview on Hypercoagulability in COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32748336>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32748336>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all